October 30|A-share Evening News: The Latest Information! Summary of announcements of major events of listed companies
【Announcement of Listed Companies】
1. Changjiang Securities: The net profit in the third quarter of 2023 was 93.4454 million yuan, a year-on-year decrease of 40.57%.
2. Huayi Group: Net profit in the third quarter of 2023 was 552 million yuan, a year-on-year increase of 413.38%.
3. Jinan Guoji: It is planned to invest no more than 400 million yuan in Ningguo Jin'an copper clad laminate project.
4. Shahe shares: 56.04 million yuan in the third quarter of 2023, a year-on-year decrease of 60.31%.
5. Gan & Lee Pharmaceutical: net profit of 132 million yuan in the third quarter of 2023 and 266 million yuan in the first three quarters.
6. China Railway Construction: Net profit in the third quarter of 2023 was 5.771 billion yuan, a year-on-year increase of 9.34%.
7. Lanwei Medical: The actual controller and chairman proposed to repurchase 15 million yuan to 30 million yuan of the company's shares.
8. Bank of China: net profit in the third quarter was 54.763 billion yuan, a year-on-year increase of 3.3%.
9. ST Sansheng: The drug chlorperine hydrochloride tablets of a wholly-owned subsidiary passed the consistency evaluation of generic drugs.
10. Yizumi: It is planned to repurchase the company's shares with 120 million yuan to 200 million yuan.
11. Tong Ren Tang: Net profit in the third quarter of 2023 increased by 55.81% year-on-year.
12. Energy-saving Tiehan: pre-won the bid for the first phase of the construction project of 5 blue roads including Shafu River in Bao'an District, Shenzhen.
13. CITIC Securities: Net profit in the third quarter of 2023 decreased by 4.9% year-on-year.
14. Jiechuang Intelligence: Won the bid for the construction project of 84.596 million yuan.
15. Sainz: The controlling shareholder Gao Weirong plans to increase his holdings by 10 million yuan to 12 million yuan.
16. Haier Smart Home: Net profit in the third quarter of 2023 increased by 12.92% year-on-year.
17. Dongfeng shares: It is proposed to change the securities abbreviation to Dongfeng Group.
18. NAURA Huachuang: Net profit in the third quarter of 2023 increased by 16.48% year-on-year.
19. Guotai Junan: Net profit in the third quarter of 2023 increased by 40.44% year-on-year.
20. Yili shares: net profit in the third quarter of 2023 increased by 59.44% year-on-year.
21. Baiyunshan: Net profit in the third quarter of 2023 increased by 10.81% year-on-year.
22. Ling Yunguang: The controlling shareholder proposed to repurchase shares for 30 million yuan to 60 million yuan.
23. HNA Holdings: net profit of 2.495 billion yuan in the third quarter of 2023.
24. Wanda Film: net profit in the third quarter was 690 million yuan, a year-on-year increase of 1340.97%.
25. Tianlong shares: net profit in the third quarter of 2023 decreased by 2.46% year-on-year.
26. Huadian Heavy Industry: Signed a procurement contract of 261 million yuan for six pipelines, pipe fittings and factory preparation of ultra-supercritical coal-fired units.
27. Everbright Bank: Net profit attributable to shareholders in the third quarter of 2023 increased by 2.45% year-on-year.
28. Zeyu Intelligence: The controlling shareholder proposed to repurchase shares for 80 million yuan to 120 million yuan.
29. CICC: Net profit in the third quarter of 2023 was 1.047 billion yuan, down 51.76% year-on-year.
30. Tiancheng Automation: The subsidiary received the notice of designation of the SAIC project.
31. Guoxin Technology: The company's research and development of new automotive electronics PSI5 transceiver special chip products have been successfully tested internally.
32. Medicilon: The chairman proposed to repurchase shares of 20 million yuan to 40 million yuan.
33. Zhongbei Communication: Net profit in the third quarter of 2023 increased by 18.13% year-on-year.
34. Bank of China: Further increase the intensity of fee reduction and interest concession.
35. China Satellite: Net profit in the third quarter of 2023 decreased by 55.1% year-on-year.
36. CanSino: The net loss in the third quarter of 2023 was 144 million yuan, and the net loss in the first three quarters was 985 million yuan.
37. Kehua Data: has been involved in the construction of supercomputing centers, such as the application of the company's high-power high-frequency tower crane in Xiong'an Advanced Supercomputing Center.
38. Kede CNC: 17.2 million yuan in the third quarter of 2023, a year-on-year increase of 191.15%.
39. Tianyuan Co., Ltd.: Adjust the investment in projects with an annual output of 100,000 tons of lithium iron phosphate cathode material precursors.
40. Anxu Biological: The net profit in the third quarter of 2023 was 20.06 million yuan, a year-on-year decrease of 92.12%.
41. Yuanjie Technology: 100G PAM4EML products in the test stage of the client.
42. Aidi Pharmaceutical: The actual controller intends to increase its shareholding by 5 million yuan to 10 million yuan.
43. Aerospace Nanhu: The company has related products with the ability to detect stealth aircraft.
44. Will Pharmaceutical: Net profit in the third quarter of 2023 was 24.89 million yuan, a year-on-year increase of 39.89%.
【Highlights of the tour capital】
1. We believe that the policy-related bearishness has come to an end, the large single product of medicine continues to break out to show the investment value of pharmaceutical products, at the end of the year, the medical insurance continues to negotiate and renew the superposition of the basic drug catalog, the fund's position in the medicine is hesitant to increase slightly month-on-month but compared with the history is still at a low level, standing at this point in time, the pharmaceutical sector needs to increase allocation, platform-based, R&D capabilities of companies will cross the cycle, the recommended allocation of ideas include large market capitalization PEG low leading companies, Stocks are segmented by leading companies with strong resilience (especially those that have been commercialized), and small-capitalization companies that have been at a low level but have changed.
2. Since the third quarter, the continental aviation industry has entered a real profit cycle. The three major airlines in Q3 all recorded the top three in the history of single-quarter profits; Air China is the third in history, China Southern Airlines is second in history, and China Eastern Airlines is at a record high, while the average international capacity of the industry in Q3 has only recovered about 5%, which means that the fare elasticity has begun to appear. We expect that with the further recovery of international routes, wide-body aircraft will gradually fly overseas, excess capacity will return to the international market, and the price side will be more supportive. According to the latest winter and spring time plan, the 23 winter and spring international routes are planned to be increased to 7 percent in 19 years, and the Sino-US routes have been increased again, and the international routes have made further breakthroughs. Continue to emphasize that the mainland aviation industry is expected to enter a real profit cycle from Q3, and the Spring Festival peak season in Q1 in 24 years may be more worth looking forward to. Focus on Air China, Spring Airlines, China Express Airlines, China Southern Airlines, Juneyao Airlines. #I want to be on the headlines##Micro headlines daily sign##头条创作挑战赛#
